New 2D Code Reader by Micronic Guarantees Greater Accuracy
The new device guarantees high accuracy code reading through an anti-frost system and a deep-focus image sensor.
The Rack Reader DR700, a new two-dimensional (2D) code reading device by Micronic, an independent manufacturing company located in The Netherlands, guarantees high accuracy code reading through an anti-frost system and a deep-focus image sensor.
The DR700 is designed for fast and accurate sample identification and can scan and decode a rack of data-matrix codes in seven seconds and a single tube of codes in two seconds. It has a small, space-saving benchtop footprint, is compatible with most 2D data-matrix coded tubes, and can be powered with an external power supply or a computer’s USB port.
Additionally, the device features Micronic Code Reader Software and an optional side barcode reader. The software includes an automatic code re-reading function, adjustment controls for brightness, contrast, and threshold, and an automatic code polarity recognition function.
Micronic launched the device in October 2019.
Source: Micronic
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.
